SOLESENCE INC(NASDAQ:SLSN) stock Fundamental Analysis

Fundamental Rating

We assign a fundamental rating of 4 out of 10 to SLSN. SLSN was compared to 85 industry peers in the Chemicals industry. SLSN has a medium profitability rating, but doesn't score so well on its financial health evaluation. SLSN is valied quite expensively at the moment, while it does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year SLSN was profitable.

In the past year SLSN had a positive cash flow from operations.

In multiple years SLSN reported negative net income over the last 5 years.

In multiple years SLSN reported negative operating cash flow during the last 5 years.

1.2 Ratios

SLSN has a better Return On Assets (8.47%) than 91.76% of its industry peers.

The Return On Equity of SLSN (28.34%) is better than 96.47% of its industry peers.

The Return On Invested Capital of SLSN (14.36%) is better than 95.29% of its industry peers.

		Industry Rank	Sector Rank
ROA	8.47%
ROE	28.34%
ROIC	14.36%

ROA(3y)-4.23%

ROA(5y)0.56%

ROE(3y)-82.95%

ROE(5y)-36.3%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

SLSN has a Profit Margin of 8.09%. This is in the better half of the industry: SLSN outperforms 80.00% of its industry peers.

In the last couple of years the Profit Margin of SLSN has remained more or less at the same level.

Looking at the Operating Margin, with a value of 9.81%, SLSN is in line with its industry, outperforming 52.94% of the companies in the same industry.

In the last couple of years the Operating Margin of SLSN has grown nicely.

SLSN has a Gross Margin of 30.92%. This is comparable to the rest of the industry: SLSN outperforms 58.82% of its industry peers.

In the last couple of years the Gross Margin of SLSN has grown nicely.

		Industry Rank	Sector Rank
OM	9.81%
PM (TTM)	8.09%
GM	30.92%

OM growth 3Y4.13%

OM growth 5YN/A

PM growth 3Y0.93%

PM growth 5YN/A

GM growth 3Y1.61%

GM growth 5Y8.11%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), SLSN is creating some value.

The number of shares outstanding for SLSN has been increased compared to 1 year ago.

The number of shares outstanding for SLSN has been increased compared to 5 years ago.

SLSN has a better debt/assets ratio than last year.

2.2 Solvency

An Altman-Z score of 3.25 indicates that SLSN is not in any danger for bankruptcy at the moment.

With a decent Altman-Z score value of 3.25, SLSN is doing good in the industry, outperforming 78.82% of the companies in the same industry.

A Debt/Equity ratio of 0.27 indicates that SLSN is not too dependend on debt financing.

SLSN's Debt to Equity ratio of 0.27 is fine compared to the rest of the industry. SLSN outperforms 76.47% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.27
Debt/FCF	N/A
Altman-Z	3.25

ROIC/WACC1.59

WACC9.02%

2.3 Liquidity

SLSN has a Current Ratio of 1.14. This is a normal value and indicates that SLSN is financially healthy and should not expect problems in meeting its short term obligations.

With a Current ratio value of 1.14, SLSN is not doing good in the industry: 82.35% of the companies in the same industry are doing better.

A Quick Ratio of 0.35 indicates that SLSN may have some problems paying its short term obligations.

SLSN has a Quick ratio of 0.35. This is amonst the worse of the industry: SLSN underperforms 91.76% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.14
Quick Ratio	0.35

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 180.00% over the past year.

The Earnings Per Share has been growing by 9.20% on average over the past years. This is quite good.

The Revenue has grown by 40.35% in the past year. This is a very strong growth!

Measured over the past years, SLSN shows a very strong growth in Revenue. The Revenue has been growing by 33.15% on average per year.

EPS 1Y (TTM)180%

EPS 3Y9.2%

EPS 5YN/A

EPS Q2Q%-100%

Revenue 1Y (TTM)40.35%

Revenue growth 3Y21.09%

Revenue growth 5Y33.15%

Sales Q2Q%48.26%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 97.50, the valuation of SLSN can be described as expensive.

Based on the Price/Earnings ratio, SLSN is valued a bit more expensive than 67.06% of the companies in the same industry.

The average S&P500 Price/Earnings ratio is at 26.70. SLSN is valued rather expensively when compared to this.

		Industry Rank	Sector Rank
PE	97.5
Fwd PE	N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SLSN is valued a bit more expensive than 78.82% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	44.23

4.3 Compensation for Growth

The decent profitability rating of SLSN may justify a higher PE ratio.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for SLSN!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

SOLESENCE INC

NASDAQ:SLSN (5/20/2025, 4:30:02 PM)

3.9

+0.07 (+1.83%)

Chartmill FA Rating

GICS SectorMaterials

GICS IndustryGroupMaterials

GICS IndustryChemicals

Earnings (Last)05-05 2025-05-05/amc

Earnings (Next)08-04 2025-08-04

Inst Owners0.98%

Inst Owner ChangeN/A

Ins Owners36.68%

Ins Owner ChangeN/A

Market Cap273.39M

AnalystsN/A

Price TargetN/A

Short Float %0.1%

Short Ratio0.19

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr YearsN/A

Div Non Decr YearsN/A

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	97.5
Fwd PE	N/A
P/S	5.22
P/FCF	N/A
P/OCF	138.71
P/B	18.29
P/tB	18.29
EV/EBITDA	44.23

EPS(TTM)0.04

EY1.03%

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)-0.04

FCFYN/A

OCF(TTM)0.03

OCFY0.72%

SpS0.75

BVpS0.21

TBVpS0.21

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	8.47%
ROE	28.34%
ROCE	21.19%
ROIC	14.36%
ROICexc	15.12%
ROICexgc	15.12%
OM	9.81%
PM (TTM)	8.09%
GM	30.92%
FCFM	N/A

ROA(3y)-4.23%

ROA(5y)0.56%

ROE(3y)-82.95%

ROE(5y)-36.3%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3Y17.57%

ROICexcg growth 5YN/A

ROICexc growth 3Y17.57%

ROICexc growth 5YN/A

OM growth 3Y4.13%

OM growth 5YN/A

PM growth 3Y0.93%

PM growth 5YN/A

GM growth 3Y1.61%

GM growth 5Y8.11%

F-Score6

Asset Turnover1.05

Health

		Industry Rank	Sector Rank
Debt/Equity	0.27
Debt/FCF	N/A
Debt/EBITDA	0.66
Cap/Depr	491.16%
Cap/Sales	8.71%
Interest Coverage	8.06
Cash Conversion	32.52%
Profit Quality	N/A
Current Ratio	1.14
Quick Ratio	0.35
Altman-Z	3.25

F-Score6

WACC9.02%

ROIC/WACC1.59

Cap/Depr(3y)375.85%

Cap/Depr(5y)357.51%

Cap/Sales(3y)6.36%

Cap/Sales(5y)6.11%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)180%

EPS 3Y9.2%

EPS 5YN/A

EPS Q2Q%-100%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)40.35%

Revenue growth 3Y21.09%

Revenue growth 5Y33.15%

Sales Q2Q%48.26%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y245.04%

EBIT growth 3Y26.09%

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y15.37%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y198.26%

OCF growth 3Y-5.29%

OCF growth 5YN/A

SOLESENCE INC (SLSN) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens